Jazz grows cannabinoid manufacturing ambitions with new $100M plant to specifically support manufacture of Jazz and GW’s two approved cannabis-based medicines. March 2022
Easier if Jazz Pharma just tipped in some $ to be part of EMD P3 trials Since we kick there Asses twice before
EMD-003 had a greater peak concentration and improved bioavailability compared to an equivalent dose of Epidyolex over a 24 hour period
https://hotcopper.com.au/posts/58301096/single
EMD-RX7 was shown to have more than 4 times the bioavailability compared to an equivalent dose of Epidiolex
https://hotcopper.com.au/posts/60242855/single
Jazz will invest more than $100 million into the 60,000-square-foot facility, where it plans to hire 100-plus staffers once the site is operational The plant is expected to open in 2024, and it will specifically support manufacture of Jazz and GW’s two approved cannabis-based medicines.
https://www.fiercepharma.com/pharma/jazz-and-gw-pharma-grow-cannabinoid-manufacturing-ambitions-new-100m-plant
- Forums
- ASX - By Stock
- EMD
- Ann: EMD-RX5 Dosing to Complete for Phase 1 Clinical Trial
Ann: EMD-RX5 Dosing to Complete for Phase 1 Clinical Trial, page-43
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add EMD (ASX) to my watchlist
(20min delay)
|
|||||
Last
3.3¢ |
Change
-0.001(2.94%) |
Mkt cap ! $13.70M |
Open | High | Low | Value | Volume |
3.3¢ | 3.3¢ | 3.1¢ | $6.915K | 216.5K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 22000 | 3.1¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
3.3¢ | 25000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 22000 | 0.031 |
5 | 215000 | 0.030 |
1 | 10000 | 0.029 |
4 | 292856 | 0.028 |
3 | 84035 | 0.027 |
Price($) | Vol. | No. |
---|---|---|
0.033 | 25000 | 1 |
0.034 | 77027 | 1 |
0.035 | 7664 | 1 |
0.038 | 148000 | 2 |
0.039 | 24400 | 1 |
Last trade - 15.42pm 27/09/2024 (20 minute delay) ? |
Featured News
EMD (ASX) Chart |